Data / Form D filings / Cresilon, Inc.
Cresilon, Inc.: Form D filings
Cresilon, Inc., a biotechnology company in Brooklyn, NY, filed 9 Form D notices with the SEC between 2018 and 2026. The latest, on June 26, 2026, reports $29 million sold of a $29 million offering to 217 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 122 18TH STREET, Brooklyn, NY, 11215
- Phone
- (347) 435-2226
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1728054
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | Amendment | $29,000,000 | $28,999,199 | $801 | 217 | Apr 24, 2026 | sec.gov |
| Apr 29, 2026 | New notice | $25,000,000 | $4,997,000 | $20,003,000 | 21 | Apr 24, 2026 | sec.gov |
| Dec 8, 2025 | New notice | $6,716,808 | $6,683,401 | $33,407 | 55 | Nov 21, 2025 | sec.gov |
| Sep 5, 2025 | New notice | $34,797,261 | $17,172,969 | $17,624,292 | 95 | Apr 11, 2025 | sec.gov |
| Jan 31, 2025 | New notice | $25,000,000 | $24,999,967 | $33 | 237 | Apr 18, 2024 | sec.gov |
| Oct 8, 2024 | New notice | $38,006,240 | $17,243,350 | $20,762,890 | 309 | Aug 3, 2023 | sec.gov |
| Oct 18, 2022 | New notice | $25,000,000 | $24,999,999 | $1 | 308 | Dec 17, 2021 | sec.gov |
| Feb 16, 2021 | New notice | $45,289,600 | $24,464,276 | $20,825,324 | 170 | Jan 29, 2021 | sec.gov |
| Jan 12, 2018 | New notice | $19,338,000 | $13,338,000 | $6,000,000 | 55 | Dec 29, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph Landolina | Executive Officer, Director | |
| Isaac Miller | Director | |
| Scott Levine | Executive Officer |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Jun 22, 2026 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cresilon, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.